NCT04976309View on ClinicalTrials.gov

A Single Dose Study of Lu AG09222 in a Headache Model With Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

July 15, 2021

Primary Completion Date

September 19, 2021

Study Completion Date

December 10, 2021

Conditions

Healthy

Interventions

DRUG

Lu AG09222

Single dose

DRUG

Placebo

Single dose

Trial Locations (1)

2600

Danish Headache Center Rigshospitalet Glostrup, Glostrup Municipality

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY